Tech Company Inital Public Offerings
Bellicum Pharmaceuticals IPO
On 12/19/2014, Bellicum Pharmaceuticals went public.
Transaction Overview
Company Name
Announced On
12/19/2014
Transaction Type
IPO
Amount
$139,650,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2130 West Holcombe Blvd. 800
Houston, TX 77030
USA
Houston, TX 77030
USA
Phone
Website
Email Address
Overview
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Fair
VP - Bus. Development
Gregory Naeve
VP - Finance
Rosie Williams
VP - Manufacturing
Joseph Senesac
VP - Operations
Alan Smith
VP - Product Management
Aaron Foster
Browse more venture capital transactions:
Prev: 12/19/2014: Rinovum Women's Health venture capital transaction
Next: 12/19/2014: Groundfloor venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs